Patient Access Solutions, Inc.
PASO · OTC
10/31/2021 | 10/31/2020 | 10/31/2019 | 10/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.01 | -0.21 | -0.03 |
| FCF Yield | -125.12% | 0.41% | 2.45% | -27.11% |
| EV / EBITDA | -0.75 | -4.70 | 12.29 | 4.20 |
| Quality | ||||
| ROIC | 874.71% | 1,328.95% | 18.05% | 27.83% |
| Gross Margin | 100.00% | 100.00% | 99.70% | 100.15% |
| Cash Conversion Ratio | 0.97 | -0.02 | 0.27 | -0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | -39.01% | -35.26% | -27.48% | 41.86% |
| Free Cash Flow Growth | -7,569.11% | 6.50% | 119.70% | -72,463.50% |
| Safety | ||||
| Net Debt / EBITDA | -0.08 | -0.13 | 1.11 | 0.88 |
| Interest Coverage | -3,245.89 | -17,508.55 | 353.58 | 26.67 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.39 | -0.39 |
| Cash Conversion Cycle | 0.00 | 0.00 | -15,069.42 | 20,799.80 |